Skip to content

A randomized, double-blind, placebo-controlled, parallel-group clinical trial on the efficacy and safety of Qinshen Qingrun Herbal Toothpaste for inhibiting dental plaque.

A randomized, double-blind, placebo-controlled, parallel-group clinical trial on the efficacy and safety of Qinshen Qingrun Herbal Toothpaste for inhibiting dental plaque.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127329
Enrollment
Unknown
Registered
2026-06-29
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Plaque

Interventions

Intervention Group:Brushing teeth with Qinshen Qingrun Herbal Toothpaste following the Modified Bass brushing technique.

Sponsors

West China Hospital of Stomatology, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Healthy male or female individuals aged 18 to 65 years (inclusive). 2.In good general health, free from significant systemic diseases. 3.Have at least 20 evaluable teeth (with healthy oral conditions, no orthodontic appliances, no full-coverage restorations, no acute gingivitis or other periodontal diseases, no carious lesions requiring treatment, no pulpal or periapical pathologies). 4.Able to read, sign, and receive a signed copy of the informed consent form. 5.Willing and able to comply with scheduled visit times, treatment plan, and other study procedures. 6.Not participating in any other clinical trial during the study period. 7.Agree to refrain from using any non-study toothpaste or mouthwash during the trial. 8.Agree to postpone any non-emergency dental examination, including dental prophylaxis (scaling), until the completion of the trial follow-up.

Exclusion criteria

Exclusion criteria: 1.Presence of severe oral diseases or chronic systemic diseases. 2.Advanced periodontitis or receipt of periodontal treatment (including periodontal surgery) within the past year. 3.Presence of open carious lesions or oral mucosal lesions. 4.Known allergy to the toothpaste or any of its ingredients. 5.Women who are pregnant or lactating. 6.Use of any of the following medications within one month prior to study enrollment: antibiotics,anticonvulsants, antihistamines, antidepressants, sedatives, or tranquilizers. 7.Prior use of any other anti-plaque toothpaste. 8.Concurrent participation in another similar clinical trial. 9.Any disease or condition that, in the investigator’s judgment, may interfere with the study procedures or compromise the subject’s ability to safely complete the trial.

Design outcomes

Primary

MeasureTime frame
Plaque Index(PLI );

Secondary

MeasureTime frame
Oral soft and hard tissue safety examination (OSHT);

Countries

China

Contacts

Public ContactXian Liu

West China Hospital of Stomatology, Sichuan University

18109066740@163.com+86 28 8550 1452

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026